Macrophage regulation of the erythron

NIH RePORTER · NIH · R01 · $469,625 · view on reporter.nih.gov ↗

Abstract

Abstract The overall aim of this proposal is to bring together the respective expertise of the Elliott and Palis labs in macrophage and erythroid biology, respectively, to better understand the role of bone marrow-resident macrophages in the regulation red blood cell production. While great progress has been made recently in understanding macrophage heterogeneity and tissue-specific function in many organs, including brain, skin, lungs, intestines, liver, and spleen, comparatively little is known about the diversity of macrophages in the bone marrow, where macrophages are key players in providing the microenvironmental niche for maturing erythroid precursors within “erythroblastic islands.” In Aim 1, we will employ functional tests of multidimensional flow cytometric data to better define the diversity of erythroid-associated macrophages (EA-Macs) in the bone marrow. Adult humans synthesize 2.5 million new red blood cells every second to maintain our circulating red cell mass, which constitutes >80% of all the cells in the body. Terminal erythroblasts in mammals enucleate to yield reticulocytes and pyrenocytes. An important function of EA-Macs is pyrenocyte clearance via phagocytosis. In Aim 2 we will test the function of CD47 “don't eat me” signals in the differential clearance of pyrenocytes but not erythroblasts. In addition, we will investigate the role of erythropoietin, the primary regulator of red cell production, in regulating the capacity of EA-Macs to clear pyrenocytes. Erythropoietin promotes the survival of late stage erythroid progenitors and immature erythroblasts, which together constitute the erythropoietin-responsive compartment of the erythron. Our preliminary studies in two independent- radiation and phlebotomy- models of stress erythropoiesis indicate that erythropoietin expands the erythropoietin-responsive compartment in the bone marrow in a macrophage-dependent manner. In Aim 3, we will test the novel hypothesis that EA-Macs mediate recovery from acute anemia by critically regulating the erythropoietin-responsive compartment. Taken together these studies will establish fundamental insights regarding the microenvironmental regulation of the erythron by EA-Macs in the bone marrow and will lay the groundwork for the future study of the role of EA-Macs in disease states of erythroid over- and under- production.

Key facts

NIH application ID
10440460
Project number
5R01DK119285-04
Recipient
UNIVERSITY OF ROCHESTER
Principal Investigator
Michael Rusty Elliott
Activity code
R01
Funding institute
NIH
Fiscal year
2022
Award amount
$469,625
Award type
5
Project period
2019-09-01 → 2024-06-30